These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 9195136

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics and pharmacodynamics of a recombinant human granulocyte colony-stimulating factor.
    Kuwabara T, Kobayashi S, Sugiyama Y.
    Drug Metab Rev; 1996 Nov; 28(4):625-58. PubMed ID: 8959393
    [Abstract] [Full Text] [Related]

  • 24. The role of polymorphonuclear neutrophils (PMNs) in clearance of granulocyte colony-stimulating factor (G-CSF) in vivo and in vitro.
    Ericson SG, Gao H, Gericke GH, Lewis LD.
    Exp Hematol; 1997 Dec; 25(13):1313-25. PubMed ID: 9406990
    [Abstract] [Full Text] [Related]

  • 25. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study.
    Bönig H, Silbermann S, Weller S, Kirschke R, Körholz D, Janssen G, Göbel U, Nürnberger W.
    Bone Marrow Transplant; 2001 Aug; 28(3):259-64. PubMed ID: 11535993
    [Abstract] [Full Text] [Related]

  • 26. Nonlinear pharmacokinetics of a recombinant human granulocyte colony-stimulating factor derivative (nartograstim): species differences among rats, monkeys and humans.
    Kuwabara T, Kato Y, Kobayashi S, Suzuki H, Sugiyama Y.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1535-43. PubMed ID: 7527856
    [Abstract] [Full Text] [Related]

  • 27. Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral blood in mice.
    Honda K, Takenaka K, Shinagawa K, Ishimaru F, Ikeda K, Niiya K, Harada M.
    Bone Marrow Transplant; 2001 Aug; 28(4):329-34. PubMed ID: 11571503
    [Abstract] [Full Text] [Related]

  • 28. Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients.
    Terashi K, Oka M, Ohdo S, Furukubo T, Ikeda C, Fukuda M, Soda H, Higuchi S, Kohno S.
    Antimicrob Agents Chemother; 1999 Jan; 43(1):21-4. PubMed ID: 9869559
    [Abstract] [Full Text] [Related]

  • 29. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
    Cavallaro AM, Lilleby K, Majolino I, Storb R, Appelbaum FR, Rowley SD, Bensinger WI.
    Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
    [Abstract] [Full Text] [Related]

  • 30. Superior mobilisation of haematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors.
    Fischer JC, Frick M, Wassmuth R, Platz A, Punzel M, Wernet P.
    Br J Haematol; 2005 Sep; 130(5):740-6. PubMed ID: 16115131
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G, Ahlin A, Dahllöf G, Elinder G, Henter JI, Palmblad J.
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [Abstract] [Full Text] [Related]

  • 32. Differences in functional activity and antigen expression of granulocytes primed in vivo with filgrastim, lenograstim, or pegfilgrastim.
    Ribeiro D, Veldwijk MR, Benner A, Laufs S, Wenz F, Ho AD, Fruehauf S.
    Transfusion; 2007 Jun; 47(6):969-80. PubMed ID: 17524085
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics and pharmacodynamics of recombinant human granulocyte colony-stimulating factor (rhG-CSF) following intranasal administration in rabbits.
    Watanabe Y, Matsumoto Y, Kikuchi R, Kiriyama M, Nakagawa K, Nomura H, Maruyama K, Matsumoto M.
    J Drug Target; 1995 Jun; 3(3):231-8. PubMed ID: 8705257
    [Abstract] [Full Text] [Related]

  • 34. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S, Shi YK, Liu P, Han XH, He XH, Cai YM, Chen ZM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [Abstract] [Full Text] [Related]

  • 35. In vivo pharmacokinetics and pharmacodynamics of positional isomers of mono-PEGylated recombinant human granulocyte colony stimulating factor in rats.
    Kang JS, Lee KC.
    Biol Pharm Bull; 2013 Jun; 36(7):1146-51. PubMed ID: 23811564
    [Abstract] [Full Text] [Related]

  • 36. Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor.
    Lee M, Aoki M, Kondo T, Kobayashi K, Okumura K, Komori K, Murohara T.
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2535-41. PubMed ID: 16224058
    [Abstract] [Full Text] [Related]

  • 37. The optimal dose of glycosylated recombinant human granulocyte colony stimulating factor for use in clinical practice: a review.
    Marty M.
    Eur J Cancer; 1994 Dec; 30A Suppl 3():S20-5. PubMed ID: 7535068
    [Abstract] [Full Text] [Related]

  • 38. Influence of renal and hepatic failure on the pharmacokinetics of recombinant human granulocyte colony-stimulating factor (KRN8601) in the rat.
    Tanaka H, Tokiwa T.
    Cancer Res; 1990 Oct 15; 50(20):6615-9. PubMed ID: 1698539
    [Abstract] [Full Text] [Related]

  • 39. fMLP-induced CD11b/CD18 upregulation on neutrophils from patients with non-Hodgkin's lymphomas treated with recombinant human granulocyte colony-stimulating factor.
    Carulli G, Azzarà A, Minnucci S, Angiolini C, Sbrana S, Ambrogi F.
    J Exp Clin Cancer Res; 1997 Sep 15; 16(3):301-8. PubMed ID: 9387905
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by recombinant granulocyte colony-stimulating factor (rhG-CSF): comparison between intravenous and subcutaneous administration.
    Sugiura M, Yamamoto K, Sawada Y, Iga T.
    Biol Pharm Bull; 1997 Jun 15; 20(6):684-9. PubMed ID: 9212991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.